Monopar Therapeutics MNPR
NASDAQ MNPR
$77.97 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Monopar Therapeutics (MNPR) Interest & Investment Income (2023 - 2026)

Updated

Monopar Therapeutics (MNPR) recorded Interest & Investment Income of $1.3 million in Q2 2026, up 66.4% from $780,769 a year earlier.

Analysis

Monopar Therapeutics (MNPR) Interest & Investment Income (2023 - 2026) Analysis & Trends

On a TTM basis, Monopar Therapeutics' Interest & Investment Income came in at $3.33 million as of Jun 30, 2026, up 114.9% year-over-year.

  • The Q2 2026 figure is the highest quarterly Interest & Investment Income in data going back to Q3 2023.
  • On a year-over-year basis, Interest & Investment Income rose in four of the last five quarters, with growth averaging 440.7%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 219.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 80.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Monopar Therapeutics 666.05 Mn 384.28 Mn - 1.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.30 Mn
Sep 30, 2025 655,473.00
Jun 30, 2025 780,769.00
Mar 31, 2025 596,845.00
Sep 30, 2024 99,344.00
Jun 30, 2024 73,475.00
Mar 31, 2024 82,165.00
Sep 30, 2023 112,260.00
API Access

Monopar Therapeutics Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=MNPR&period=max&api_key=YOUR_API_KEY